Announcements Trials
Browse Landscape

Phase

Phase NA 89Phase 2 20Phase 3 10Phase 1 8Phase 4 7Phase 1/2 5Phase 2/3 4

Status

Completed 4Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 318INDUSTRY 101NIH 18NETWORK 16OTHER_GOV 10UNKNOWN 4FED 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Uterine Cervical Dysplasia 1Prostatic Neoplasms 1Ototoxicity 1Lymphatic Abnormalities 1Lymphangioma, Cystic 1Lymphangioma 1

Interventions

Thioctic Acid 1Picibanil 1Imiquimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × FED × Clear all
NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed
22 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00010452 2015-03-25

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

FDA Office of Orphan Products Development

Phase 2/3 Completed
150 enrolled

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

NCT00477607 2014-03-07

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

VA Office of Research and Development

Phase 2/3 Completed
39 enrolled 11 charts

Ototoxicity

NCT00164437 2005-09-14

CD-ROM Intervention for Prostate Cancer Screening

Centers for Disease Control and Prevention

Phase 2/3 Completed
554 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡